These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26805906)

  • 1. Global assays in hemophilia.
    Chitlur M; Young G
    Semin Hematol; 2016 Jan; 53(1):40-5. PubMed ID: 26805906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the laboratory analyses of bleeding disorders.
    Chitlur M
    Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central role of thrombin in bleeding disorders.
    Negrier C; Shima M; Hoffman M
    Blood Rev; 2019 Nov; 38():100582. PubMed ID: 31164248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives.
    Young G; Sørensen B; Dargaud Y; Negrier C; Brummel-Ziedins K; Key NS
    Blood; 2013 Mar; 121(11):1944-50. PubMed ID: 23319573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin Generation Assays (TGAs).
    Salvagno GL; Berntorp E
    Methods Mol Biol; 2017; 1646():515-522. PubMed ID: 28804851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation testing for monitoring hemophilia treatment: a clinical perspective.
    Salvagno GL; Berntorp E
    Semin Thromb Hemost; 2010 Oct; 36(7):780-90. PubMed ID: 20978999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches for measuring coagulation.
    Barrowcliffe TW; Cattaneo M; Podda GM; Bucciarelli P; Lussana F; Lecchi A; Toh CH; Hemker HC; Béguin S; Ingerslev J; Sørensen B
    Haemophilia; 2006 Jul; 12 Suppl 3():76-81. PubMed ID: 16684000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utility of thromboelastography in the treatment of acquired hemophilia A].
    Wang S; Nagaharu K; Suzuki K; Hachiya K; Nishimura K; Matsumoto T; Tawara I
    Rinsho Ketsueki; 2023; 64(5):338-342. PubMed ID: 37271522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation and implications for hemophilia therapies: A narrative review.
    Sidonio RF; Hoffman M; Kenet G; Dargaud Y
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100018. PubMed ID: 36798897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global haemostasis assays, from bench to bedside.
    van Geffen M; van Heerde WL
    Thromb Res; 2012 Jun; 129(6):681-7. PubMed ID: 22221936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic heterogeneity of hemostasis in severe hemophilia.
    Nogami K; Shima M
    Semin Thromb Hemost; 2015 Nov; 41(8):826-31. PubMed ID: 25615433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment.
    Haisma B; Schols SEM; van Oerle RGM; Verbeek-Knobbe K; Hellenbrand D; Verwoerd EJ; Heubel-Moenen FCJI; Stroobants AK; Meijer D; Rijpma SR; Henskens YMC
    Thromb Res; 2024 Aug; 240():109045. PubMed ID: 38834002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired hemophilia A].
    Amano K
    Rinsho Ketsueki; 2018; 59(6):756-763. PubMed ID: 29973457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A.
    Muczynski V; Verhenne S; Casari C; Chérel G; Panicot-Dubois L; Gueguen P; Trossaert M; Dubois C; Lenting PJ; Denis CV; Christophe OD
    Thromb Haemost; 2019 Dec; 119(12):1981-1993. PubMed ID: 31639831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tests of hemostatic function in patients with abnormal bleeding; application and interpretation.
    TOCANTINS LM
    Med Clin North Am; 1946 Nov; 30():1361-75. PubMed ID: 20276581
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of Thrombin Generation Assay in Patients With Hemophilia.
    Haghpanah S; Bazrafshan A; Silavizadeh S; Dehghani J; Afrasiabi A; Karimi M
    Clin Appl Thromb Hemost; 2016 May; 22(4):322-6. PubMed ID: 25354749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endogenous thrombin potential in practical use].
    Wilkens M
    Hamostaseologie; 2011 May; 31(2):88-93. PubMed ID: 21152675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.